CAS NO: | 2451856-97-4 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | Mupadolimab (CPI-006) is an IgG1κ humanized FcγR binding-deficient anti-CD73monoclonal antibody (mAb) that activatesCD73POSB cells[1]. | ||||||||
IC50& Target | CD73[1] | ||||||||
体外研究 (In Vitro) | Mupadolimab induces the increased expression of markers associated with B cell maturation and antigen presentation, morphologic transformation to plasmablasts, and increased secretion of IgM and IgG[1]. | ||||||||
体内研究 (In Vivo) | Mupadolimab (10 mg/kg; i.p.; daily for 15 days) stimulates antigen specific humoral immunity in SARS-CoV-2 infected NSG-SGM3 mice[1].
| ||||||||
Clinical Trial | |||||||||
性状 | Liquid | ||||||||
CAS 号 | 2451856-97-4 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |